We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+4.95%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.32B
AUM Growth
+$4.28M
Cap. Flow
-$57M
Cap. Flow %
-1.71%
Top 10 Hldgs %
26.79%
Holding
356
New
26
Increased
46
Reduced
192
Closed
18

Top Buys

Rank Stock Value
1
PCOR icon
Procore
PCOR
+$20.6M
2
MNDY icon
monday.com
MNDY
+$19.6M
3
ESE icon
ESCO Technologies
ESE
+$12M
4
GENI icon
Genius Sports
GENI
+$9.81M
5
MIR icon
Mirion Technologies
MIR
+$9.58M

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$27.3M
2
NET icon
Cloudflare
NET
+$25.3M
3
HAE icon
Haemonetics
HAE
+$12.3M
4
BOW
Bowhead Specialty Holdings
BOW
+$10.5M
5
AVTR icon
Avantor
AVTR
+$9.22M

Sector Composition

Rank Sector Weight
1 Technology 30.18%
2 Healthcare 14.43%
3 Financials 14.41%
4 Consumer Discretionary 13.76%
5 Industrials 10.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLMR icon
101
Palomar
PLMR
$3.47B
$8.86M 0.27%
75,894
+6,792
+10% +$861K
DBRG icon
102
DigitalBridge
DBRG
$2.95B
$8.66M 0.26%
740,405
-19,504
-3% -$218K
ELF icon
103
e.l.f. Beauty
ELF
$5.61B
$8.59M 0.26%
64,859
-6,914
-10% -$853K
PHIN icon
104
Phinia Inc
PHIN
$2.74B
$8.57M 0.26%
149,030
-440
-0.3% -$23.8K
FOLD
105
DELISTED
Amicus Therapeutics
FOLD
$8.54M 0.26%
1,084,278
+72,178
+7% +$514K
CYTK icon
106
Cytokinetics
CYTK
$10.6B
$8.49M 0.26%
154,449
-4,079
-3% -$168K
YETI icon
107
Yeti Holdings
YETI
$3.85B
$8.35M 0.25%
+251,538
New +$8.79M
PRVA icon
108
Privia Health
PRVA
$2.81B
$8.33M 0.25%
334,559
-8,733
-3% -$188K
KNSA icon
109
Kiniksa Pharmaceuticals
KNSA
$6.07B
$8.32M 0.25%
214,364
-74,272
-26% -$2.41M
NBIX icon
110
Neurocrine Biosciences
NBIX
$16.5B
$8.26M 0.25%
58,844
-8,225
-12% -$1.11M
TWST icon
111
Twist Bioscience
TWST
$7.72B
$8.22M 0.25%
292,153
+75,571
+35% +$2.29M
ALGM icon
112
Allegro MicroSystems
ALGM
$7.93B
$8.01M 0.24%
274,477
+39,552
+17% +$1.28M
WGS icon
113
GeneDx Holdings
WGS
$2.44B
$8M 0.24%
74,247
-11,516
-13% -$1.25M
VITL icon
114
Vital Farms
VITL
$496M
$7.98M 0.24%
193,894
-5,090
-3% -$221K
NCNO icon
115
nCino
NCNO
$2.1B
$7.97M 0.24%
294,143
+149
+0.1% +$4.35K
LGN
116
Legence Corp
LGN
$4.99B
$7.89M 0.24%
+256,247
New +$8.07M
AXSM icon
117
Axsome Therapeutics
AXSM
$11.1B
$7.84M 0.24%
64,521
-8,947
-12% -$1.01M
ADPT icon
118
Adaptive Biotechnologies
ADPT
$4.04B
$7.82M 0.24%
522,802
-179,909
-26% -$2.19M
ONT
119
Onterris Inc
ONT
$576M
$7.8M 0.23%
283,899
+40,393
+17% +$1.06M
ADMA icon
120
ADMA Biologics
ADMA
$2.22B
$7.78M 0.23%
530,524
+73,868
+16% +$1.27M
LTH icon
121
Life Time Group Holdings
LTH
$9.79B
$7.73M 0.23%
280,249
-7,405
-3% -$211K
ALKS icon
122
Alkermes
ALKS
$8.26B
$7.73M 0.23%
257,795
-6,825
-3% -$192K
TMDX icon
123
Transmedics
TMDX
$3.1B
$7.68M 0.23%
68,406
+9,676
+16% +$1.13M
FORM icon
124
FormFactor
FORM
$9.46B
$7.57M 0.23%
207,718
-5,494
-3% -$177K
BIRK icon
125
Birkenstock
BIRK
$6.89B
$7.55M 0.23%
166,829
-4,420
-3% -$216K
3 4
5
6 7

Similar funds

CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Peregrine Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Peregrine Capital Management held 356 positions worth $3.32B, up 0.13% from $3.32B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Peregrine Capital Management's Q3 2025 filing shows 26 new, 46 increased, 192 reduced and 18 closed positions. Its largest new stake was ESCO Technologies: 60,443 shares worth $12.8M. The largest sale was Adobe, an estimated $27.3M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Financials.

  • Peregrine Capital Management's largest Q3 2025 buy was ESCO Technologies: 60,443 shares worth $12.8M.
  • Peregrine Capital Management added most to Procore in Q3 2025, an estimated $20.6M increase.
  • Peregrine Capital Management's biggest Q3 2025 reduction was Cloudflare, cutting an estimated $25.3M.
  • Peregrine Capital Management fully exited Adobe in Q3 2025, selling an estimated $27.3M.
  • Peregrine Capital Management's ten largest holdings make up 27% of its $3.32B portfolio in Q3 2025.
  • Peregrine Capital Management opened 26 new positions and closed 18 in Q3 2025.
  • Peregrine Capital Management's portfolio value rose 0.13% quarter-over-quarter to $3.32B.

Based on Peregrine Capital Management's 13F filing for Q3 2025, filed 23 Oct 2025.